Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase NA 3Phase 1 3Phase 1/2 1

Status

Completed 73Active not recruiting 20Recruiting 19Unknown 17Terminated 16Not yet recruiting 5Withdrawn 3Suspended 2

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Sarcoma 5Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 134Breast Neoplasms 94Colorectal Neoplasms 65Carcinoma, Hepatocellular 57Squamous Cell Carcinoma of Head and Neck 48Stomach Neoplasms 46Lung Neoplasms 45Triple Negative Breast Neoplasms 43Prostatic Neoplasms 43Leukemia, Myeloid, Acute 43Small Cell Lung Carcinoma 41Uterine Cervical Neoplasms 40Rectal Neoplasms 37Neoplasms 31Pancreatic Neoplasms 30Recurrence 29Neoplasm Metastasis 29Esophageal Squamous Cell Carcinoma 25Esophageal Neoplasms 24Ovarian Neoplasms 23Nasopharyngeal Carcinoma 21Brain Neoplasms 21Melanoma 20Lymphoma, Large B-Cell, Diffuse 20Colonic Neoplasms 20Carcinoma, Renal Cell 20Head and Neck Neoplasms 19Endometrial Neoplasms 19Multiple Myeloma 18Biliary Tract Neoplasms 18

Interventions

irinotecan sucrosofate 1envafolimab 1Vincristine 1Temozolomide 1Neoadjuvant Therapy 1Methotrexate 1Brachytherapy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Not yet recruiting × Osteosarcoma × Clear all
NCT07560826 2026-05-01

The CATSINDO Trial - Clinical and Translational Study in Newly Diagnosed Osteosarcoma

Wake Forest University Health Sciences

Phase 2 Not yet recruiting
46 enrolled
Sarcoma

Osteosarcoma

NCT07444918 2026-03-03

Liposomal Irinotecan, Vincristine, Temozolomide, and Anlotinib for R/R Pediatric Solid Tumors

Tianjin Medical University Cancer Institute and Hospital

Phase 2 Not yet recruiting
33 enrolled
Sarcoma

Recurrence, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma

NCT07142863 2025-08-27

Envafolimab Combined With Neoadjuvant Chemotherapy Treat Stage IIb Resectable Osteosarcoma Patients

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Phase 2 Not yet recruiting
23 enrolled
Sarcoma

Osteosarcoma

NCT06524778 2024-08-07

Single High-dose Brachytherapy for Giant Osteosarcoma Masses

Shanghai Jiao Tong University Affiliated Sixth People's Hospital

Phase 2 Not yet recruiting
16 enrolled
Sarcoma

Osteosarcoma

NCT06041490 2023-09-18

Adjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver Transplantation

Peking Union Medical College Hospital

Phase 2 Not yet recruiting
88 enrolled
GastrointestinalSarcoma

Carcinoma, Hepatocellular, Recurrence, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡